HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tobias Kamphuis Selected Research

Vaccines

12/2022Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
4/2013Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
8/2010Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tobias Kamphuis Research Topics

Disease

3Infections
03/2016 - 08/2010
2Respiratory Syncytial Virus Infections
11/2013 - 04/2013
2Virus Diseases (Viral Diseases)
11/2013 - 04/2013
1COVID-19
12/2022
1Breakthrough Infections
12/2022

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
12/2022 - 08/2010
2VirosomesIBA
11/2013 - 04/2013
2Respiratory Syncytial Virus VaccinesIBA
11/2013 - 04/2013
2CytokinesIBA
11/2013 - 04/2013
1Ad26COVS1IBA
12/2022
1Viral RNAIBA
03/2016
1Proteins (Proteins, Gene)FDA Link
03/2016
1Interleukin-5 (Interleukin 5)IBA
11/2013
1Interleukin-4 (Interleukin 4)IBA
11/2013
1Interleukin-13IBA
11/2013
1Neutralizing AntibodiesIBA
11/2013

Therapy/Procedure

1Injections
12/2022